Hu J - Search Results

1

The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Hu J, Yan J, Rao G, Latha K, Overwijk WW, Heimberger AB, Li S. Hu J, et al. Int Rev Immunol. 2016 Jul 3;35(4):325-339. doi: 10.3109/08830185.2014.956360. Epub 2014 Sep 26. Int Rev Immunol. 2016. PMID: 25259408 Free PMC article. Review.

2

Herceptin conjugates linked by EDC boost direct tumor cell death via programmed tumor cell necrosis.

Hu J, Liu X, Hughes D, Esteva FJ, Liu B, Chandra J, Li S. Hu J, et al. PLoS One. 2011;6(8):e23270. doi: 10.1371/journal.pone.0023270. Epub 2011 Aug 10. PLoS One. 2011. PMID: 21853100 Free PMC article.

3

Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells.

Hu J, Vien LT, Xia X, Bover L, Li S. Hu J, et al. Biol Proced Online. 2014 Feb 4;16(1):3. doi: 10.1186/1480-9222-16-3. Biol Proced Online. 2014. PMID: 24495546 Free PMC article.

4

The impact of non-electrical factors on electrical gene transfer.

Hu J, Cutrera J, Li S. Hu J, et al. Methods Mol Biol. 2014;1121:47-54. doi: 10.1007/978-1-4614-9632-8_3. Methods Mol Biol. 2014. PMID: 24510810 Free PMC article. Review.

5

Electroporation formulation for cell therapy.

Hu J, Li S. Hu J, et al. Methods Mol Biol. 2014;1121:55-60. doi: 10.1007/978-1-4614-9632-8_4. Methods Mol Biol. 2014. PMID: 24510811 Free PMC article.

6

CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors.

Hu J, Zhu S, Xia X, Zhang L, Kleinerman ES, Li S. Hu J, et al. Mol Cancer. 2014 Feb 24;13:34. doi: 10.1186/1476-4598-13-34. Mol Cancer. 2014. PMID: 24565056 Free PMC article.

7

Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells.

Noh H, Hu J, Wang X, Xia X, Satelli A, Li S. Noh H, et al. Among authors: hu j. Cell Commun Signal. 2015 Feb 27;13:14. doi: 10.1186/s12964-015-0093-y. Cell Commun Signal. 2015. PMID: 25889536 Free PMC article.

8

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Yan J, Kong LY, Hu J, Gabrusiewicz K, Dibra D, Xia X, Heimberger AB, Li S. Yan J, et al. Among authors: hu j. J Natl Cancer Inst. 2015 May 13;107(8):djv137. doi: 10.1093/jnci/djv137. Print 2015 Aug. J Natl Cancer Inst. 2015. PMID: 25971300 Free PMC article.

9

Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells.

Yan J, Mitra A, Hu J, Cutrera JJ, Xia X, Doetschman T, Gagea M, Mishra L, Li S. Yan J, et al. Among authors: hu j. J Hepatol. 2016 May;64(5):1128-1136. doi: 10.1016/j.jhep.2015.12.020. Epub 2016 Jan 6. J Hepatol. 2016. PMID: 26767500 Free PMC article.

10

Corrigendum to "Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells".

Yan J, Mitra A, Hu J, Cutrera JJ, Xia X, Doetschman T, Gagea M, Mishra L, Li S. Yan J, et al. Among authors: hu j. J Hepatol. 2016 May 27:S0168-8278(16)30180-5. doi: 10.1016/j.jhep.2016.04.028. Online ahead of print. J Hepatol. 2016. PMID: 27241198 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,855 results

Search Page

Filters